Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nuvation Bio Inc (NY: NUVB )

3.080 +0.200 (+6.94%)
Official Closing Price Updated: 7:00 PM EDT, Aug 15, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 866,669
Open 2.860
Bid (Size) 2.950 (10)
Ask (Size) 3.150 (1)
Prev. Close 2.880
Today's Range 2.860 - 3.120
52wk Range 2.250 - 10.45
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Nuvation Bio Reports Second Quarter 2022 Financial Results and Provides Business Update
From Nuvation Bio Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday's session saw 51 companies set new 52-week lows. 
Via Benzinga

Performance

YTD
-65.12%
-65.12%
1 Month
-14.68%
-14.68%
3 Month
-23.95%
-23.95%
6 Month
-40.77%
-40.77%
1 Year
-63.07%
-63.07%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
After FDA Hold, Nuvation Bio Stops NUV-422 Cancer Development Program
Via Benzinga
Short Volatility Alert: Nuvation Bio Inc.
Via Benzinga
FDA Institutes Partial Hold On Nuvation Bio's Early-Stage Solid Tumor Trial - Read Why
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Nuvation Bio Announces Discontinuation of NUV-422 Clinical Development Program
From Nuvation Bio Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Nuvation Bio Appoints David Liu, M.D., Ph.D., as Chief Medical Officer and Kerry Wentworth as Chief Regulatory Officer
From Nuvation Bio Inc.
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Nuvation Bio Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Nuvation Bio Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Nuvation Bio Announces FDA Partial Clinical Hold for Phase 1 Study of NUV-422 in Solid Tumors
From Nuvation Bio Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
77 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Nuvation Bio Reports First Quarter 2022 Financial Results and Provides Business Update
From Nuvation Bio Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.